Atosiban is a representative drug of oxytocin receptor antagonists and has a good effect on preterm's treatment. It inhibits oxytocin's effect competitively by binding to oxytocin receptor on myometrial and decidual. It also prevents the second messager formation and calcium mobilization. The studies up to date have shown that Atosiban effectively inhibits uterine contractions with little side effects. The article briefly summarizes the current understanding of Atosiban.
Result Analysis
Print
Save
E-mail